AEON Biopharma, Inc. (AEON)Healthcare | Biotechnology | Irvine, United States | NYSE American
0.31 USD
+0.02
(6.907%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.30 -0.01 (-0.011%) ⇩ (Aug. 28, 2026, 7:58 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:39 a.m. EDT
The immediate outlook is severely bearish as the stock has collapsed from $0.30 to $0.19 in just two weeks, trading well below its 50-day average and facing heavy selling pressure. While analysts offer a 'strong buy' recommendation with a target price significantly higher than the current level, this optimism is disconnected from the reality of a biotech company with negative earnings, negative free cash flow, and a book value in the red. The recent news of a massive public offering and debt restructuring suggests the company is desperate for capital to stay alive rather than thriving. Furthermore, the price history reveals a catastrophic multi-year decline, dropping nearly 99.7% over the last two years, which indicates a fundamental breakdown in the business model or market perception that is unlikely to reverse quickly. There is no dividend to provide any cushion for investors. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.475614 |
| MSTL | 0.538277 |
| AutoARIMA | 0.543168 |
| AutoETS | 0.543169 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 25% |
| H-stat | 274.73 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.039 |
| Excess Kurtosis | -1.80 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 15,673,174 |
| Forward P/E | -1.26 |
| Beta | 0.64 |
| Website | https://www.aeonbiopharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6043069 |
| Address1 | 5 Park Plaza |
| Address2 | Suite 1750 |
| All Time High | 1,236.24 |
| All Time Low | 0.177 |
| Ask | 0.315 |
| Ask Size | 200 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 7,985,040 |
| Average Daily Volume3 Month | 2,599,516 |
| Average Volume | 2,599,516 |
| Average Volume10Days | 7,985,040 |
| Beta | 0.644 |
| Bid | 0.286 |
| Bid Size | 900 |
| Book Value | -0.584 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.3142 |
| Current Ratio | 0.544 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.3147 |
| Day Low | 0.2805 |
| Display Name | AEON Biopharma |
| Ebitda | -19,818,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.758 |
| Enterprise Value | 15,017,173 |
| Eps Current Year | -0.455 |
| Eps Forward | -0.25 |
| Eps Trailing Twelve Months | -4.86 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.39844 |
| Fifty Day Average Change | -0.08423999 |
| Fifty Day Average Change Percent | -0.21142453 |
| Fifty Two Week Change Percent | -60.430687 |
| Fifty Two Week High | 1.45 |
| Fifty Two Week High Change | -1.1358 |
| Fifty Two Week High Change Percent | -0.7833103 |
| Fifty Two Week Low | 0.177 |
| Fifty Two Week Low Change | 0.13720001 |
| Fifty Two Week Low Change Percent | 0.7751413 |
| Fifty Two Week Range | 0.177 - 1.45 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,672,756,200,000 |
| Float Shares | 24,010,083 |
| Forward Eps | -0.25 |
| Forward P E | -1.2568 |
| Free Cashflow | -7,187,000 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 8 |
| Fullday Change | 0.0203 |
| Fullday Change Percent | 6.90711 |
| Fullday Price | 0.3031 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.53472 |
| Held Percent Institutions | 0.32749 |
| Implied Shares Outstanding | 49,882,790 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-14 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,740,528,000 |
| Last Split Factor | 1:72 |
| Long Business Summary | AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California. |
| Long Name | AEON Biopharma, Inc. |
| Market | us_market |
| Market Cap | 15,673,174 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_247856902 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -54,623,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 14,660,551 |
| Number Of Analyst Opinions | 3 |
| Open | 0.299 |
| Operating Cashflow | -13,642,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 949 354 6499 |
| Post Market Change | -0.011100024 |
| Post Market Change Percent | -3.5327892 |
| Post Market Price | 0.3031 |
| Post Market Time | 1,787,961,535 |
| Previous Close | 0.2939 |
| Price Eps Current Year | -0.69054943 |
| Price Hint | 4 |
| Price To Book | -0.53801376 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.467 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.0203 |
| Regular Market Change Percent | 6.90711 |
| Regular Market Day High | 0.3147 |
| Regular Market Day Low | 0.2805 |
| Regular Market Day Range | 0.2805 - 0.3147 |
| Regular Market Open | 0.299 |
| Regular Market Previous Close | 0.2939 |
| Regular Market Price | 0.3142 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 1,097,411 |
| Return On Assets | -1.4153199 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 49,882,790 |
| Shares Percent Shares Out | 0.0226 |
| Shares Short | 1,126,698 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,112,789 |
| Short Name | AEON Biopharma, Inc. |
| Short Percent Of Float | 0.03 |
| Short Ratio | 0.42 |
| Source Interval | 15 |
| State | CA |
| Symbol | AEON |
| Target High Price | 2.1 |
| Target Low Price | 1.0 |
| Target Mean Price | 1.43333 |
| Target Median Price | 1.2 |
| Total Cash | 3,431,000 |
| Total Cash Per Share | 0.069 |
| Total Debt | 2,775,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.86 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.83003 |
| Two Hundred Day Average Change | -0.51583004 |
| Two Hundred Day Average Change Percent | -0.6214595 |
| Type Disp | Equity |
| Volume | 1,097,411 |
| Website | https://www.aeonbiopharma.com |
| Zip | 92,614 |